Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies.
Rodrigues Carvalho ML, de Oliveira Andrade C, Cabral-Piccin MP, Kinker GS, Vitiello GAF, Gonçalves Cambuí RA, de Macedo Abdo L, Mannarino Correia E, da Silva Elias BD, Araujo EVO, Chaves AS, Pereira PHB, Hajdu KL, Rondinelli A, Fagotti Gusmão A, Marques Pierre ML, Brasil-Costa I, Pouza Zanella C, Moreira Lemos MM, Batista MV, Filho JS, Arrowsmith C, Cordeiro de Lima VC, Bonamino MH, da Silva Medina T.
Rodrigues Carvalho ML, et al. Among authors: rondinelli a.
Cancer Res. 2025 Jun 16;85(12):2234-2249. doi: 10.1158/0008-5472.CAN-24-1643.
Cancer Res. 2025.
PMID: 39970330